QU

Quantum Base Holdings PLC

IL

Overview

Corporate Details

ISIN(s):
GB00BTXYPJ53
LEI:
9845002F5A9EY5AM4B40
Country:
United Kingdom
Address:
N/A
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Quantum Base Holdings PLC is a quantum science company specializing in anti-counterfeiting and authentication technology. Its core product, Q-ID®, is a unique and uncopiable 'atomic-level fingerprint' that can be applied to products, packaging, and documents. The technology enables instant verification using any standard smartphone, providing a highly scalable and accessible solution for brand protection, supply chain security, and document verification. The company's solution is designed for low-cost integration with existing printing processes and is deployed through partnerships with global security organizations.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Quantum Base Holdings PLC. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-07-28 08:00
Board/Management Information
Appointment of Non-Executive Director
English 17.0 KB

Automate Your Workflow. Get a real-time feed of all Quantum Base Holdings PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Quantum Base Holdings PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Kancera Logo
Develops drugs targeting the fractalkine axis for severe inflammation and resistant cancers.
Sweden KAN
Lidds AB Logo
Develops a drug delivery platform for local, sustained-release oncology treatments.
Sweden LIDDS
Lineage Cell Therapeutics Inc. Logo
Developing off-the-shelf cell therapies to restore function in neurological & retinal diseases.
Israel LCTX
Lipidor AB Logo
Develops topical skin disease drugs using a lipid-based drug delivery platform.
Sweden LIPI
Lipigon Pharmaceuticals AB Logo
Develops RNA and small-molecule drugs for rare, lipid-related disorders.
Sweden LPGO
Lipum AB Logo
Develops novel antibody therapies for chronic inflammatory diseases like rheumatoid arthritis.
Sweden LIPUM
LYSOGENE Logo France LYS
Lytix Biopharma AS Logo
Develops oncolytic peptides that kill cancer cells and stimulate an anti-tumor immune response.
Norway LYTIX
Matricelf Ltd. Logo
Engineering autologous 3D tissue implants from patient cells to treat spinal cord injuries.
Israel MTLF
Mazaro N.V. Logo
Engineering patented, high-efficiency transmissions for vehicles and industrial drivelines.
Belgium MLMAZ